[go: up one dir, main page]

NO20032217L - Type III-sekresjonsrute i Aeromonas salmonicida og anvendelse derav - Google Patents

Type III-sekresjonsrute i Aeromonas salmonicida og anvendelse derav

Info

Publication number
NO20032217L
NO20032217L NO20032217A NO20032217A NO20032217L NO 20032217 L NO20032217 L NO 20032217L NO 20032217 A NO20032217 A NO 20032217A NO 20032217 A NO20032217 A NO 20032217A NO 20032217 L NO20032217 L NO 20032217L
Authority
NO
Norway
Prior art keywords
type iii
iii secretion
aeromonas salmonicida
secretion route
route
Prior art date
Application number
NO20032217A
Other languages
English (en)
Other versions
NO20032217D0 (no
NO335842B1 (no
Inventor
Joachim Frey
Julian C Thornton
Michael A Kuzik
Jan Burian
Katja Stuber
Original Assignee
Univ Bern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bern filed Critical Univ Bern
Publication of NO20032217D0 publication Critical patent/NO20032217D0/no
Publication of NO20032217L publication Critical patent/NO20032217L/no
Publication of NO335842B1 publication Critical patent/NO335842B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
NO20032217A 2000-11-15 2003-05-15 Aeromonas calcium respons D polypetid og isolert nukleinsyrefragment samt anvendelse av disse. NO335842B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24886400P 2000-11-15 2000-11-15
PCT/CA2001/001589 WO2002040514A2 (en) 2000-11-15 2001-11-15 Type iii secretion pathway in aeromonas salmonicida, and uses therefor

Publications (3)

Publication Number Publication Date
NO20032217D0 NO20032217D0 (no) 2003-05-15
NO20032217L true NO20032217L (no) 2003-07-09
NO335842B1 NO335842B1 (no) 2015-03-02

Family

ID=22941002

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20032217A NO335842B1 (no) 2000-11-15 2003-05-15 Aeromonas calcium respons D polypetid og isolert nukleinsyrefragment samt anvendelse av disse.
NO20032218A NO335752B1 (no) 2000-11-15 2003-05-15 Eksoenzymtoksin og nukleinsyrefragment fra Aeromonas salmonicida, vaksine og anvendelse derav samt fremgangsmåte for indusering av toksinet.
NO20141517A NO20141517L (no) 2000-11-15 2014-12-17 Ny type III-sekresjonsvei i Aeromonas salmonicida og anvendelse derav

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20032218A NO335752B1 (no) 2000-11-15 2003-05-15 Eksoenzymtoksin og nukleinsyrefragment fra Aeromonas salmonicida, vaksine og anvendelse derav samt fremgangsmåte for indusering av toksinet.
NO20141517A NO20141517L (no) 2000-11-15 2014-12-17 Ny type III-sekresjonsvei i Aeromonas salmonicida og anvendelse derav

Country Status (6)

Country Link
US (6) US7351550B2 (no)
AU (2) AU2002223328A1 (no)
CA (4) CA2707684C (no)
GB (2) GB2389112A (no)
NO (3) NO335842B1 (no)
WO (2) WO2002040514A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007339423B2 (en) * 2006-08-14 2012-11-15 Biocontrol Systems, Inc. Method for detecting pathogens
WO2009145829A1 (en) 2008-04-01 2009-12-03 University Of Massachusetts Type iii secretion inhibitors, analogs and uses thereof
EP2432501B1 (en) * 2009-05-22 2016-12-14 The Institute for Systems Biology Secretion-related bacterial proteins for nlrc4 stimulation
CN108251341B (zh) * 2018-03-27 2020-11-06 北京鼎持生物技术有限公司 一种铜绿假单胞菌以及含该菌的海洋哺乳动物疫苗
EP3906050A1 (en) 2018-12-31 2021-11-10 Bellevacc AS Bacterial vaccine
CN110922454B (zh) * 2019-12-05 2020-11-06 中国科学院深圳先进技术研究院 绿脓杆菌毒素ExoS和ExoT的免疫用途及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112310D0 (en) 1991-06-07 1991-07-24 United Kingdom Government Fish vaccine
GB2308367B (en) 1995-12-22 1999-10-13 Scottish Salmon Growers Ass Aeromonas protein used as a vaccine component

Also Published As

Publication number Publication date
CA2749307C (en) 2015-03-17
GB2389112A (en) 2003-12-03
WO2002040514A2 (en) 2002-05-23
NO20032217D0 (no) 2003-05-15
US7815896B2 (en) 2010-10-19
NO20141517L (no) 2003-07-09
WO2002040515A3 (en) 2002-12-27
GB0313912D0 (en) 2003-07-23
GB2385854A (en) 2003-09-03
CA2707684C (en) 2013-12-24
AU2002214891A1 (en) 2002-05-27
AU2002223328A1 (en) 2002-05-27
CA2467360C (en) 2016-08-16
US20070269462A1 (en) 2007-11-22
US20050158344A1 (en) 2005-07-21
US7851197B2 (en) 2010-12-14
US20100008895A1 (en) 2010-01-14
US20090074817A1 (en) 2009-03-19
US7579011B2 (en) 2009-08-25
WO2002040515A2 (en) 2002-05-23
NO20032218D0 (no) 2003-05-15
GB0313840D0 (en) 2003-07-23
NO20032218L (no) 2003-07-14
CA2467360A1 (en) 2002-05-23
CA2749307A1 (en) 2002-05-23
US20050058662A1 (en) 2005-03-17
CA2467309A1 (en) 2002-05-23
US7538208B2 (en) 2009-05-26
US7232569B2 (en) 2007-06-19
CA2707684A1 (en) 2002-05-23
NO335752B1 (no) 2015-02-02
CA2467309C (en) 2014-08-26
US7351550B2 (en) 2008-04-01
US20090226462A1 (en) 2009-09-10
WO2002040514A3 (en) 2002-12-27
NO335842B1 (no) 2015-03-02

Similar Documents

Publication Publication Date Title
IS6885A (is) Burðarefni ásamt fíbrínógeni og þrombíni á föstu formi
NO20020343L (no) Kaspase-inhibitorer og anvendelse derav
FI20000819A0 (fi) Menetelmä vastaanottimessa ja vastaanotin
NO20025018D0 (no) Selektiv hydroprosessering og merkaptanfjerning
DK1305301T3 (da) Alpha-acyl- og alpha-heteroatomsubstituerede benzenacetamidglucokinase-aktivatorer
NO20014553D0 (no) Brönnplanlegging og konstruksjon
IS6411A (is) Kaspasa tálmar og notkun þeirra
CY2008006I1 (el) Παραγωγα τροπανιου χρησιμα στη θepαπευτικη
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
NO20031848D0 (no) Polyuretan elastomer gel isolerende sammensetning og anvendelse derav
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20025158L (no) Lipidpreparat og anvendelse derav
DK1254240T3 (da) Hybrid protease med reduceret antigenicitet og dens anvendelse
NO20030882L (no) Glasskeramikkmasse og anvendelse derav
DE60045563D1 (de) Personenförderanlage
NO20032217D0 (no) Type III sekresjonsrute i Aeromonas salmonicida og anvendelse derav
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20014946D0 (no) Strukturerte flerbrukspakninger og deres anvendelse
NO20032010D0 (no) Ikke-aspirerende overgangsviskosielastikker for anvendelse i kirurgi
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
NO20013534D0 (no) Blodströmsforbedringsmidler og trombose-hemmere eller - remedier
DE50105857D1 (de) Phenoxyphenyl alkansulfonate
NO20025135L (no) Antihypertensive midler og anvendelse
NO20024029L (no) Nytt protein og gen som koder for proteinet

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS POSTBOKS 2003 VIKA OSLO, 0125 NO

MK1K Patent expired